About Option Care Health, Inc. - Common Stock (OPCH)
Option Care Health Inc is a leading provider of home and alternate site infusion services in the United States. The company specializes in delivering personalized intravenous (IV) medication therapies to patients in the comfort of their homes or in outpatient settings, focusing on critical care, oncology, and infectious diseases. Through a network of experienced healthcare professionals, Option Care Health ensures high-quality patient care and treatment, while also emphasizing collaboration with healthcare providers to improve health outcomes and enhance the overall patient experience. The company aims to be a trusted partner in the healthcare continuum, offering innovative solutions tailored to individual patient needs. Read More
Shares of alternate site health provider Option Care Health (NASDAQ:OPCH)
fell 5.8% in the morning session after its third-quarter earnings was overshadowed by a full-year outlook that failed to impress investors.
Alternate site health provider Option Care Health (NASDAQ:OPCH) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 12.2% year on year to $1.44 billion. The company expects the full year’s revenue to be around $5.63 billion, close to analysts’ estimates. Its non-GAAP profit of $0.45 per share was 5.1% above analysts’ consensus estimates.
Option Care Health posts mixed Q3 results, beating earnings estimates but missing on revenue. The stock fell as investors reacted to the revenue miss and conservative full-year guidance.
BANNOCKBURN, Ill., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the third quarter ended September 30, 2025.
Alternate site health provider Option Care Health (NASDAQ:OPCH)
will be reporting earnings this Thursday before market hours. Here’s what investors should know.
Wall Street has set ambitious price targets for the stocks in this article.
While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.
Shares of alternate site health provider Option Care Health (NASDAQ:OPCH)
jumped 3.2% in the afternoon session after Morgan Stanley initiated coverage on the stock with an 'Overweight' rating and a $35 price target. The new rating from analyst Erin Wright signaled a bullish view on the company's future performance. The price target represented a notable premium to where the shares previously traded. The positive outlook was reportedly based on Option Care Health's leading position in the market for home and alternative-site infusion services. This sector was viewed as expanding due to the rising prevalence of chronic diseases and a general shift in healthcare toward lower-cost settings.
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on.
However, these companies often come with higher volatility and risk, as their smaller size makes them more vulnerable to economic downturns.
Option Care Health Inc's (NYSE: OPCH) short interest as a percent of float has risen 19.11% since its last report. According to exchange reported data, there are now 5.55 million shares sold short, which is 5.36% of all regular shares that are available for trading.
BANNOCKBURN, Ill., Sept. 25, 2025 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, today announced that the company will release results for its third quarter ended September 30, 2025 on Thursday, October 30, 2025 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day.
Shares of alternate site health provider Option Care Health (NASDAQ:OPCH)
fell 3.1% in the afternoon session after investor concerns grew over ongoing contract negotiations for its key drug, Stelara, following a significant price reduction mandated by the Inflation Reduction Act (IRA).
Option Care Health (OPCH) offers strong growth in home infusion services at a reasonable valuation, presenting a balanced investment opportunity in healthcare.
Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.
Discover OPTION CARE HEALTH (OPCH), an affordable growth stock with strong earnings, solid profitability, and a reasonable valuation for sustainable expansion.
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%.
But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.
OPCH stock shows strong fundamentals with accelerating EPS growth and a promising technical breakout pattern, positioning it for potential upward momentum.
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns.
Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.
BANNOCKBURN, Ill., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, will participate in the following upcoming investor conferences:
A number of stocks fell in the afternoon session after the major indices continued to pull back, with technology stocks accounting for most of the market's largest decliners. A key reason for this trend is that much of the recent market gains were concentrated in the "AI trade," which includes these large technology and semiconductor companies. So this could also mean that some investors are locking in some gains ahead of more definitive feedback from the Fed.
Looking back on senior health, home health & hospice stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Option Care Health (NASDAQ:OPCH) and its peers.
